Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntuitive Investment Group Regulatory News (IIG)

Share Price Information for Intuitive Investment Group (IIG)

Share Price is delayed by 15 minutes
Get Live Data
234.00    8.00 (3.45%)
Bid:
228.00
Ask:
240.00
Spread: 12.00 (5.263%)
Market Cap: £574.33m
IIG Live PriceLast checked at - London Stock Exchange

Intraday Intuitive Investment Group Share Chart

Trading Statement

3 Jan 2006 08:30

iimia Investment Group plc3 January 2006Trading Statementiimia Investment Group plc ("iimia" or the "Group"), the Exeter-based financialservices group, is issuing this trading update prior to entering the closeperiod before the announcement, expected to be by the end of March 2006, of itspreliminary results for the year ended 31 December 2005.Overview * Group traded profitably in the second half and for the year as a whole * Intelli acquisition completed successfully at the end of September * Cost cutting exercise referred to in interim report has been implemented with positive results Trading updateGenerally, market conditions have provided a more favourable backdrop to theGroup's activities. Furthermore, the Directors have been able to concentratetheir focus more on the future development of the Group after a period ofdistraction caused by legacy issues.Investment Servicesiimia continues to enjoy good investment performance, enabling the fundmanagement division to accrue meaningful performance fees. This has beenassisted by increasing inflows into the Group's OEICs. The Directors believethat the cost base in the Group's retail business is now more suited toactivity levels.Administration ServicesSinclair Henderson continues to win new business, although it is still managingthe loss of business arising from the liquidation of a number of split capitalinvestment trusts. Furthermore, as a result of a takeover by an internationalbank, a significant client has given notice to terminate its administrationcontract. The Administration business, therefore is looking to develop newsources of business, such as in Guernsey, where Sinclair Henderson has beenauthorised to conduct business by the Guernsey Financial Services Commission.Corporate FinanceSince its acquisition at the end of September, Intelli Corporate Finance hastraded very profitably generating significant revenues from a number ofsuccessful assignments.OutlookThe contribution made to the Group's profitability in the second half byIntelli together with the improvement in the rest of iimia's businesses, willenable the Group to report a profit for the year ended 31 December 2005.iimia expects to make further progress in 2006, while continuing to develop itsexisting businesses and taking an opportunistic approach to value addingopportunities.Further information on iimia can be found atwww.iimia.co.ukEnquiries:iimiaMichael Phillips Chief Executive 07973 141998William Long Chairman 01392 475951BroadgateRoland Cross 020 7726 6111ENDIIMIA INVESTMENT GROUP PLC
Date   Source Headline
12th Oct 20219:48 amRNSLight Science Technologies - Intention To Float
20th Sep 20218:04 amRNSLight Science Technologies Holdings - update
15th Sep 20217:00 amRNSInvestment in Momentum Bioscience Limited
20th Aug 20213:40 pmRNSDirector Dealing
29th Jun 202110:56 amRNSInvestment in Midatech Pharma PLC
2nd Jun 20217:00 amRNSInterim report
28th May 20212:18 pmRNSInvestment in Trellus Health plc
4th May 20217:00 amRNSInvestment in The Electrospinning Company Limited
9th Apr 202111:01 amRNSIssue of Shares and Total Voting Rights
1st Apr 20217:00 amRNSInvestment in Axol Bioscience Ltd
31st Mar 20214:18 pmRNSInvestment in Altair
31st Mar 202112:00 pmRNSInvestment in CardiNor AS
17th Mar 20217:00 amRNSInvestment in Polarean Imaging plc
16th Mar 20217:00 amRNSInvestment in Micrima Limited
1st Mar 20217:00 amRNSInvestment in Shield Therapeutics plc
22nd Feb 20217:00 amRNSInvestment in Yourgene Health plc
12th Feb 202111:41 amRNSProposed Investment in Kromek Pharma plc
8th Feb 202111:08 amRNSHolding(s) in Company
3rd Feb 20217:00 amRNSProposed Investment in Evgen Pharma plc
29th Jan 20217:00 amRNSPortfolio company BioQ Pharma receives CE mark
25th Jan 20217:00 amRNSProposed Investment in Microsaic Systems plc
21st Jan 20214:41 pmRNSSecond Price Monitoring Extn
21st Jan 20214:35 pmRNSPrice Monitoring Extension
21st Jan 20217:00 amRNSInvestment in BioQ Pharma
11th Jan 20217:00 amRNSPre-IPO Investment in Light Science Technologies
14th Dec 20207:00 amRNSAIM Admission & First Day of Dealings
17th Jul 200610:58 amPRNDirector/PDMR Shareholding
30th Jun 200610:19 amPRNIssue of Equity
20th Jun 20063:08 pmPRNDirector/PDMR Shareholding
2nd Jun 200612:20 pmPRNCorrection : Holding(s) in Company
2nd Jun 200612:05 pmPRNHolding(s) in Company
16th May 200610:35 amPRNDirector/PDMR Shareholding
8th May 20062:30 pmPRNAdditional Listing
27th Apr 20061:07 pmPRNDirectorate Change
13th Apr 20069:46 amPRNDirector/PDMR Shareholding
23rd Mar 20064:53 pmPRNAdditional Listing
13th Mar 200610:41 amPRNDirector/PDMR Shareholding
8th Mar 20063:42 pmPRNNotice of Results
22nd Feb 20064:45 pmPRNDirector/PDMR Shareholding
18th Jan 20065:07 pmPRNDirector/PDMR Shareholding
3rd Jan 20068:30 amPRNTrading Statement
21st Dec 20052:54 pmPRNAdditional Listing
20th Dec 200512:16 pmPRNDirector/PDMR Shareholding
20th Dec 200510:51 amPRNAllotment of Shares
12th Oct 20054:18 pmPRNCirc re Interim Results
4th Oct 20052:44 pmPRNAllotment of shares
29th Sep 20059:40 amPRNHolding(s) in Company
29th Sep 20059:35 amPRNDirectorate Change
29th Sep 20056:00 amPRNInterim Results
29th Sep 20056:00 amPRNAcquisition(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.